Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.
PURPOSE: Hepatocellular carcinoma (HCC) is the sixth most common solid tumor worldwide and the third leading cause of cancer-related death. HCC is a particularly serious threat to the Chinese population. Although many molecular alterations are known to be involved in the tumorigenesis of hepatocytes...
Main Authors: | Xiao Ding, Yuan Yang, Baoda Han, Chengzhi Du, Naiqing Xu, Huanwei Huang, Tao Cai, Aiqun Zhang, Ze-Guang Han, Weiping Zhou, Liang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4010419?pdf=render |
Similar Items
-
An Integrative Analysis Reveals the Underlying Association Between CTNNB1 Mutation and Immunotherapy in Hepatocellular Carcinoma
by: Zhuomao Mo, et al.
Published: (2020-06-01) -
Investigation of CTNNB1 gene mutations and expression in hepatocellular carcinoma and cirrhosis in association with hepatitis B virus infection
by: Davod Javanmard, et al.
Published: (2020-06-01) -
Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma
by: Stine Karlsen Oversoe, et al.
Published: (2021-04-01) -
Detection of <i>CTNNB1</i> Hotspot Mutations in Cell-Free DNA from the Urine of Hepatocellular Carcinoma Patients
by: Selena Y. Lin, et al.
Published: (2021-08-01) -
ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis
by: Jeffrey C. To, et al.
Published: (2021-04-01)